Covered recipient · General Payments record
DAVID PETER MOUALLEM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$7,429.81
- Reported across 563 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $485.93 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $199.30 | 15 |
| GlaxoSmithKline, LLC. | $63.04 | 4 |
| Novo Nordisk AS | $36.59 | 2 |
| Lilly USA, LLC | $34.78 | 2 |
| ABBVIE INC. | $30.22 | 1 |
| E.R. Squibb & Sons, L.L.C. | $29.50 | 2 |
| Acerta Pharma LLC | $28.23 | 2 |
| Lundbeck LLC | $20.74 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.33 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.29 | 1 |
| DEXCOM, INC. | $13.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.22 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073843 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.33 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146961968 | CMS |
| Amgen Inc. | $13.19 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333862 | CMS |
| Amgen Inc. | $20.10 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333864 | CMS |
| Amgen Inc. | $14.30 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333866 | CMS |
| Amgen Inc. | $20.33 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333868 | CMS |
| Amgen Inc. | $16.58 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333870 | CMS |
| Amgen Inc. | $14.59 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333872 | CMS |
| Amgen Inc. | $4.42 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333874 | CMS |
| Amgen Inc. | $19.32 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333876 | CMS |
| Amgen Inc. | $7.13 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333880 | CMS |
| Amgen Inc. | $10.14 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333878 | CMS |
| Amgen Inc. | $11.49 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656804 | CMS |
| Amgen Inc. | $17.36 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333882 | CMS |
| Amgen Inc. | $8.20 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333884 | CMS |
| Amgen Inc. | $5.14 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333886 | CMS |
| Amgen Inc. | $17.01 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333888 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.66 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104700619 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.57 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105894654 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.29 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118130045 | CMS |
| Dexcom, Inc. | $13.91 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295269 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101537931 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.36 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101537955 | CMS |
| GlaxoSmithKline, LLC. | $18.21 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116482881 | CMS |
| GlaxoSmithKline, LLC. | $16.55 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116614478 | CMS |
| GlaxoSmithKline, LLC. | $13.77 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116254017 | CMS |
| GlaxoSmithKline, LLC. | $14.51 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116606942 | CMS |
| Lilly USA, LLC | $15.16 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136156997 | CMS |
| Lilly USA, LLC | $19.62 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136127947 | CMS |
| Lundbeck LLC | $20.74 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948526 | CMS |
| Novo Nordisk Inc | $21.16 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097618335 | CMS |
| Novo Nordisk Inc | $15.43 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097243106 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.